Similar articles

• [Impaired glucose tolerance in children and adolescents].

  Nakanishi T, Sai S, Fujisawa Y, Nakagawa Y, Ohzeki T. Nakanishi T, et al. Nihon Rinsho. 2005 Feb;63 Suppl 2:345-8. Nihon Rinsho. 2005. PMID: 15779401 Review. Japanese. No abstract available.
• [2h-CPR/2h-PG in 75g-OGTT].

  Onouchi Z, Kunimaru S. Onouchi Z, et al. Nihon Rinsho. 2005 Feb;63 Suppl 2:394-9. Nihon Rinsho. 2005. PMID: 15779411 Review. Japanese. No abstract available.
• Plasma glucose concentration 60 min post oral glucose load and risk of type 2 diabetes and cardiovascular disease: Pathophysiological implications.

  Abbasi F, Tern PJ, Reaven GM. Abbasi F, et al. Diab Vasc Dis Res. 2019 Jul;16(4):337-343. doi: 10.1177/1479164119827239. Epub 2019 Feb 13. Diab Vasc Dis Res. 2019. PMID: 30755013
• Deficiency of total and nonglycosylated amylin in plasma characterizes subjects with impaired glucose tolerance and type 2 diabetes.

  Mäkimattila S, Fineman MS, Yki-Järvinen H. Mäkimattila S, et al. J Clin Endocrinol Metab. 2000 Aug;85(8):2822-7. doi: 10.1210/jcem.85.8.6721. J Clin Endocrinol Metab. 2000. PMID: 10946889
• [Insulin secretion and insulin sensitivity in subjects with impaired fasting glucose].

  Nishi Y, Yamada Y, Fukushima M, Seino Y. Nishi Y, et al. Nihon Rinsho. 2005 Feb;63 Suppl 2:151-4. Nihon Rinsho. 2005. PMID: 15779360 Review. Japanese. No abstract available.